Dewi Wara Shinta, Junaidi Khotib, Eddy Rahardjo, Mahardian Rahmadi, Budi Suprapti

Abstract views = 648 times | downloads = 451 times


Hydroxyethyl Starch (HES) is a compound that improves intravascular volume effectively and rapidly without causing tissue edema. However, HES also has renal safety profile which is still being debated. Based on clinical experience in Dr. Soetomo Hospital, the frequency of acute renal failure following HES 200/0.5 administration at a dose of less than 20 ml/kg (maximum dose) is very rare. The purpose of this study was to evaluate the effect of HES 200/0.5 at a dose of less than 20 ml/kg in patients undergoing surgery. N-acetyl-b-D-Glucosaminidase (NAG) per urine creatinine ratio and creatinine serum were used as main parameter to assess renal injury. This research was observational and prospective design in patients undergoing elective surgery at Gedung Bedah Pusat Terpadu, Dr. Soetomo Hospital, who requiring resuscitation therapy with HES 200/0.5 and met the inclusion and exclusion criteria. NAG was measured prior to surgery and 12 hours after administration of fluid therapy, while creatinine serum was observed before surgery and 48 hours after resuscitation. This study was conducted for three months, and obtained 50 subjects divided into 2 groups, crystalloid group and HES 200/0.5 group. Demographic and baseline characteristics did not differ between groups, except the total bleeding volume. Total bleeding in HES 200/0.5group was higher than crystalloid group (p <0.0001). The mean volume of fluid received in HES 200/0.5 group was 2042.0 ± 673.9 mL, higher when compared with that of crystalloid group (910.0 ± 592.0 ml). Doses of HES 200/0.5 received was 8.31 ± 4.86 ml/kg. Measurement of the of NAG/creatinine ratio and creatinine serum showed significant increase in both groups, but still within the normal range. In addition, the value of these two parameters did not differ between groups. In conclusion, HES 200/0.5 in a dose of less than 20 ml/kg is safe to use in patients who suffered from hypovolemic hemorrhage, without prior history of renal impairment.


hyroxyethyl starch, acute renal failure, n-acetyl--d-glucosaminidase, creatinine serum

Full Text:



Ahsan N, Palmer BF, Wheeler D, Greenlee RG Jr, Toto RD (1994). Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med 154, 1985–1987

Al-Khafaji A and Webb AR (2004). Fluid resuscitation. Contin Educ Anaesth Crit Care Pain 4, 127–131

Baron JF (2000b). Crystalloids versus colloids in the treatment of hypovolemic shock. In: Vincent JL (ed). Yearbook of Intensive Care and Emergency Medicine 2000, New York, Springer, p 443–466

Baron JF (2000a). Adverse effects of colloids on renal function. In: Vincent JL (ed). Yearbook of Intensive Care and Emergency Medicine 2000, New York, Springer, p 486–493

Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet) (2008). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358, 125-139

Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996). Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348, 1620-1622

Dehne MG, Mühling J, Sablotzki A, Dehne K, Sucke N, Hempelmann G (2001). Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth 13, 103-111

Deman A, Peeters P, Sennesael J (1999). Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant 14, 1517-1520

Diehl JT, Lester JL 3rd, Cosgrove DM (1982). Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 34, 674–679

Diomi P, Ericsson JL, Matheson NA (1970). Effects of dextran 40 on urine flow and composition during renal hypoperfusion in dogs with osmotic nephrosis. Ann Surg 172, 813–824

DiScala VA, Mautner W, Cohen JA, Levitt MF, Churg J, Yunis SL (1965). Tubular alterations produced by osmotic diuresis with mannitol. Ann Intern Med 63, 767–775

Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H (2012). Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 16, R94

Hauet T, Faure JP, Baumert H, Bardou A, Gibelin H, Beguinot S, Germonville T, Hebrard W, Choulet P, Carretier M, Eugene M (1998). Influence of different colloids on hemodynamic and renal functions: comparative study in an isolated perfused pig kidney model. Transplant Proc 30, 2796-2797

Kumle B, Boldt J, Piper S, Schmidt C, Suttner S, Salopek S (1999). The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 89, 1124-1130

Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H (1993). Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342, 248-249

Macintyre E, Mackie IJ, Ho D, Tinker J, Bullen C, Machin SJ (1985). The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med 11, 300-303

Matheson N and Diomi P (1970). Renal failure after the administration of dextran 40. Surg Gynecol Obstet 131, 661–668

Moggio RA, Rha CC, Somberg ED, Praeger PI, Pooley RW, Reed GE (1983). Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Crit Care Med 11, 943-945

Moran M and Kapsner C (1987). Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317, 150-153

Morisaki H, Bloos F, Keys J, Martin C, Neal A, Sibbald WJ (1994). Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 77, 1507-1518

Munsch CM, MacIntyre E, Machin SJ, Mackie IJ, Treasure T (1988). Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg 75, 675-678

Mutter TC, Ruth CA, Dart AB (2013). Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7, CD007594

Myburgh JA and Mythen MG (2013). Resuscitation fluids. N Engl J Med 369, 1243–1251

Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R (2003). Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 96, 1453-1459

Novikov M and Smith CE (2008). Fluid and blood therapy in trauma. International Trauma Care 18, 42–56

Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001). Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357, 911-916

Spaniol JR, Knight AR, Zebley JL, Anderson D, Pierce JD (2007). Fluid resuscitation therapy for hemorrhagic shock. J Trauma Nurs 14, 152-160

Stainsby D, MacLennan S, Hamilton PJ (2000). Management of massive blood loss: a template guideline. Br J Anaesth 85, 487-491

Standl T, Lipfert B, Reeker W, Schulte am Esch J, Lorke DE (1996). Acute effects of complete blood exchange with ultra-purified hemoglobin solution or hydroxyethyl starch on liver and kidney in the animal model. Anasthesiol Intensivmed Notfallmed Schmerzther 31, 354-361

Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA (2013). Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 309, 678-688


  • There are currently no refbacks.

Copyright (c) 2016 Dewi Wara Shinta, Junaidi Khotib, Eddy Rahardjo, Mahardian Rahmadi, Budi Suprapti

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Indexed By

View My Stats

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.